Literature DB >> 2177081

Inhibition of primary transcription of vesicular stomatitis virus by prostaglandin A1.

T Bader1, H Ankel.   

Abstract

Prostaglandin A (PGA) exhibits antiviral activity against RNA and DNA viruses. The effect of PGA1 on vesicular stomatitis virus (VSV) was investigated. When VSV-infected L-1210 cells were kept in the presence of PGA1 the amount of all five viral proteins and their respective mRNAs was dose-dependently decreased. To determine whether the effect was on viral transcription or translation, the temperature-sensitive VSV mutant tsG 41 was employed. This is a good model system for the investigation of primary transcription; at the restrictive temperature of 39 degrees C, tsG 41 is unable to replicate but can transcribe viral mRNA. Mutant mRNA synthesis was strongly inhibited by PGA1 at this temperature, indicating that the major effect is on primary transcription. This conclusion is supported by data demonstrating that in vitro transcription of viral genomic RNA was also inhibited by PGA1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177081     DOI: 10.1099/0022-1317-71-12-2823

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.

Authors:  C Rozera; A Carattoli; A De Marco; C Amici; C Giorgi; M G Santoro
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

2.  Selective inhibition of virus protein synthesis by prostaglandin A1: a translational block associated with HSP70 synthesis.

Authors:  C Amici; C Giorgi; A Rossi; M G Santoro
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 3.  Heat shock proteins and virus replication: hsp70s as mediators of the antiviral effects of prostaglandins.

Authors:  M G Santoro
Journal:  Experientia       Date:  1994-11-30

Review 4.  Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.

Authors:  Bohae Rachel Lee; May Hnin Paing; Neelam Sharma-Walia
Journal:  Front Physiol       Date:  2021-07-15       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.